What shareholders have to look forward to with UATG:
The company further outlined its strategy to expand its Biotech division with the release of its acclaimed ClearView® bone fixation system to include its revolutionary new titanium Aegis™ surgical bone pin. The company added that it anticipates the release of the Apex™ interphalangeal implant around the same time as the ClearView® product in the first quarter of 2019. This is the most significant expansion of the UAT Biotech division since the launch of the Hygieia™ product line.
TAMPA, Fla., Aug. 22, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE - Umbra Applied Technologies Group, Inc. (UATG:PK) announced today that it has delivered the first shipment of Hygieia™ antimicrobial inserts to NextCast & Brace for their production run prototypes of their advanced casting system. This signals the beginning of a five-year contract with their new strategic medical devices partner.
The company indicated that it is currently preparing to release its high-performance crew and ankle socks as well as its much-anticipated boxer briefs and bedding line. The bedding line featuring its SleepSafe technology is scheduled to be released in Q2 of this year beginning with what the company calls the most comfortable and last pillow will you every own. ( Delay with manufacturing, packaging, but has been verified by CEO product will be going to market soon. )
In the past 6 months, UAT has reorganized its debt and paid down the majority of its notes to keep in line with the company’s plan to complete its audited financials and eventually up-list to a senior exchange. This will help to strengthen the company’s banking relationships and credit lines as it prepares to expand its operations across all divisions.
UATG
